Recruiting OBSERVATIONAL NCT07243262
Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)
Sponsor: Buckinghamshire Healthcare NHS Trust
Interventions
Breath test
Updated 1 time since 2025 Last updated: Nov 21, 2025 Started: Oct 21, 2025 Primary completion: Aug 1, 2028 Completion: Aug 1, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07243262, this observational or N/A phase trial focuses on PDAC - Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer and remains actively recruiting participants. Sponsored by Buckinghamshire Healthcare NHS Trust, it has been updated 1 time since 2025, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Buckinghamshire Healthcare NHS Trust
- Dorset County Hospital NHS Foundation Trust
- Imperial College Healthcare NHS Trust
- Imperial College London
- Liverpool University Hospitals NHS Foundation Trust
- Newcastle-upon-Tyne Hospitals NHS Trust
- Pancreatic Cancer UK
- Royal Free Hospital NHS Foundation Trust
- Sherwood Forest Hospitals NHS Foundation Trust
- University Hospital Southampton NHS Foundation Trust
Data source: Imperial College London
For direct contact, visit the study record on ClinicalTrials.gov .